Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

Niels de Wind, Marleen Dekker, Anton Berns et al. · Cell · 1995 · 792 citations · Full text

Knockout Mouse, Genome Instability, Somatic Variant +8

Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP)

Nayoung Kim · Nucleic Acids Research · 1997 · 687 citations

Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry

Nathalie Rufer, Wieslawa H. Dragowska, Gayle Thornbury et al. · Nature Biotechnology · 1998 · 552 citations

Flow Cytometry, Medicine, Hematology +7

Telomeres in the mouse have large inter-chromosomal variations in the number of T ₂ AG ₃  repeats

J. M. J. M. Zijlmans, Uwe M. Martens, Steven S.S. Poon et al. · Proceedings of the National Academy of Sciences · 1997 · 492 citations · Full text

MSH2 deficient mice are viable and susceptible to lymphoid tumours

Armin Reitmair, Rudolf Schmits, Amy Ewel et al. · Nature Genetics · 1995 · 382 citations

Lymphoid Neoplasia, Msh2 Deficient Mice, Lymphocyte Development +6